Market Data
Market Cap₹15,991.79 Cr.
52W High₹567.8
Current Price₹504.5
52W Low₹402.1
Down from 52W High11.1 %
Face Value₹1
Performance
ROCE16.46 %
ROE7.33 %
EPS (TTM)₹1.43
EPS Prev Qtr₹1.25
EPS Last Year₹0.94
EBITDA Qtr₹92.1 Cr.
Book Value₹64
Financial Health
Debt/Equity0.08
Debt/Profit0.85
Total Assets₹3,941.75 Cr.
Promoter Holding32.34 %
Earning Power8.13 %
Valuation
Stock P/E107.57
Industry P/E40.99
Price to Book7.9
Price to Sales7.25
Graham Number₹82.09
Key Metrics
Face Value
₹1
About Dr Agarwals Health Care Ltd
Healthcare · Healthcare
Dr Agarwals Health Care Ltd is listed on NSE in the Healthcare / Healthcare sector. Face value ₹1. Market cap ₹15,991.79 Cr.
Price Chart
Strengths & Weaknesses
Strengths
- The company has a manageable debt-to-equity ratio of 0.13, indicating low financial risk.
- The Return on Capital Employed (ROCE) is 17%, showing efficient use of capital.
- The company has a solid promoter holding of 32.34%, suggesting strong management control.
Weaknesses
- The P/E ratio of 107.17 is significantly high, indicating the stock may be overvalued.
- The Return on Equity (ROE) is 9.92%, which is relatively low and suggests moderate efficiency in generating returns for shareholders.
- The company does not currently pay dividends, as indicated by a dividend yield of N/A.
Peer Comparison
| Name | CMP | P/E | Market Cap | Div Yield | NP Qtr | Qtr Profit Var% | Sales Qtr | Qtr Sales Var% | ROCE% | Debt/Eq |
|---|---|---|---|---|---|---|---|---|---|---|
| Apollo Hospitals Enterprise Ltd | - | 60.97 | ₹1,27,421.96 Cr | 0.23% | ₹2,172 Cr | - | ₹26,429.9 Cr | - | 22.05% | 0.6 |
| Max Healthcare Institute Ltd | - | 66.77 | ₹97,411.97 Cr | 0.2% | ₹1,457.4 Cr | - | ₹8,712.05 Cr | - | 14.38% | 0.27 |
| Manipal Health Enterprises Ltd | - | - | ₹94,970.23 Cr | - | - | - | - | - | - | 1.25 |
| Aster DM Quality Care Ltd | - | 121 | ₹65,183.66 Cr | 0.4% | ₹362.82 Cr | - | ₹4,876.03 Cr | - | 12.95% | 0.17 |
| Fortis Healthcare Ltd | - | 59.91 | ₹62,782.32 Cr | 0.12% | ₹1,070.21 Cr | - | ₹9,506.15 Cr | - | 13.34% | 0.29 |
| Global Health Ltd | - | 69.27 | ₹38,550.84 Cr | - | ₹552.33 Cr | - | ₹4,683.41 Cr | - | 21.87% | 0.1 |
| Narayana Hrudayalaya Ltd | - | 45.26 | ₹37,159.95 Cr | - | ₹816.55 Cr | - | ₹9,072.4 Cr | - | 13.65% | 1.07 |
| Dr Lal Pathlabs Ltd | - | 46.81 | ₹32,548.55 Cr | 1.26% | ₹546.3 Cr | - | ₹2,890.8 Cr | - | 29.55% | 0 |
| Krishna Institute of Medical Sciences Ltd | - | 150.24 | ₹32,180.9 Cr | - | ₹194.4 Cr | - | ₹4,212.5 Cr | - | 9.66% | 1.44 |
| Poly Medicure Ltd | - | 52.64 | ₹16,587.48 Cr | 0.21% | ₹312.92 Cr | - | ₹1,997.43 Cr | - | 15.07% | 0.06 |
| Dr Agarwals Health Care Ltd | - | 107.57 | ₹15,991.79 Cr | - | ₹185.1 Cr | - | ₹2,206.68 Cr | - | 16.46% | 0.08 |
| Vijaya Diagnostic Centre Ltd | - | 82.27 | ₹15,431.94 Cr | 0.13% | ₹187.49 Cr | - | ₹857.13 Cr | - | 36.21% | 0 |
| Syngene International Ltd | - | 68.32 | ₹15,167.87 Cr | 0.33% | ₹221 Cr | - | ₹3,600.2 Cr | - | 6.95% | 0 |
| Indegene Ltd | - | 36.68 | ₹14,769.29 Cr | 0.37% | ₹400.9 Cr | - | ₹3,812.8 Cr | - | 17.45% | 0 |
| Rainbow Childrens Medicare Ltd | - | 48.85 | ₹13,947.12 Cr | 0.25% | ₹290.28 Cr | - | ₹1,820.14 Cr | - | 27.05% | 0 |
| Molbio Diagnostics Ltd | - | - | ₹13,924.73 Cr | - | - | - | - | - | - | 0.35 |
| Park Medi World Ltd | - | 38.3 | ₹11,945.05 Cr | - | ₹296.75 Cr | - | ₹1,756.29 Cr | - | 19.17% | 0.11 |
| Metropolis Healthcare Ltd | - | 24.51 | ₹11,863.54 Cr | 0.87% | ₹202.82 Cr | - | ₹1,710 Cr | - | 19.8% | 0.01 |
| Yatharth Hospital & Trauma Care Services Ltd | - | 58.5 | ₹10,596.57 Cr | - | ₹174.45 Cr | - | ₹1,334.1 Cr | - | 11.7% | 0.14 |
| Healthcare Global Enterprises Ltd | - | 446.68 | ₹10,336.94 Cr | - | ₹33.26 Cr | - | ₹2,627.35 Cr | - | 9.41% | 0.68 |
Quarterly Results
| Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|
| Sales | 498.69 | 529.86 | 564.11 | 614.02 |
| ↳ QoQ Growth | - | +6.3% | +6.5% | +8.8% |
| Expenses | 430.41 | 454.51 | 479.32 | 521.92 |
| Operating Profit | 68.28 | 75.35 | 84.79 | 92.1 |
| OPM % | 13.69% | 14.22% | 15.03% | 15% |
| Other Income | 7.93 | 10.54 | 12.58 | 6.41 |
| Interest | 22.55 | 21.13 | 22.08 | 23.37 |
| Depreciation | 67.86 | 68.75 | 76.68 | 78.31 |
| EBITDA | 136.14 | 144.1 | 161.47 | 170.41 |
| EBITDA Margin % | 27.3% | 27.2% | 28.62% | 27.75% |
| Profit Before Tax | 53.66 | 64.76 | 76.62 | 75.14 |
| Tax % | 32% | 32.63% | 34.8% | 26.78% |
| Net Profit | 36.49 | 43.63 | 49.96 | 55.02 |
| ↳ QoQ Growth | - | +19.6% | +14.5% | +10.1% |
| EPS | 0.94 | 1.07 | 1.25 | 1.43 |
Balance Sheet
| Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|
| Equity Capital | 9.33 | 31.59 | 31.68 |
| Reserves | 1330.08 | 1835 | 1993.36 |
| Borrowings | 966.43 | 960.91 | 157.27 |
| Other Liabilities | 446.98 | 844.07 | 1759.44 |
| Total Liabilities | 2752.82 | 3671.57 | 3941.75 |
| Fixed Assets | 1020.75 | 1340.46 | 2879.46 |
| CWIP | 113.95 | 143.88 | 234.36 |
| Investments | 470.53 | 263.73 | 152.34 |
| Other Assets | 1147.59 | 1923.5 | 675.59 |
| Total Assets | 2752.82 | 3671.57 | 3941.75 |
Cash Flows
| Mar 2025 | Mar 2026 | |
|---|---|---|
| Cash from Operating Activity | 360.33 | 518.99 |
| Cash from Investing Activity | -750.33 | -308.45 |
| Cash from Financing Activity | 381.86 | -220.39 |
| Net Cash Flow | -8.14 | -9.85 |
Shareholding Pattern
| Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|
| Promoters % | 32.42% | 32.39% | 32.36% | 32.34% |
| FIIs % | 58.13% | 58.06% | 57.94% | 57.96% |
| DIIs % | 7.92% | 7.78% | 7.83% | 7.72% |
| Public % | 1.41% | 1.62% | 1.68% | 1.81% |
| No. of Shareholders | 48,168 | 46,554 | 43,538 | 42,492 |
Major Shareholders (>1%)
- Hyperion Investments Pte. Ltd.Public Shareholding23.09%
- Claymore Investments (mauritius) Pte. LtdPublic Shareholding10.19%
- Arvon Investments Pte.ltd.Public Shareholding9.87%
- Government Of SingaporePublic Shareholding6.35%
As of 2026-06-30View all shareholders →